Page last updated: 2024-09-05

erlotinib hydrochloride and Neuralgia

erlotinib hydrochloride has been researched along with Neuralgia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cameron, MG; Kersten, C; Laird, B; Mjåland, S	1

Trials

1 trial(s) available for erlotinib hydrochloride and Neuralgia

Article	Year
Epidermal growth factor receptor-inhibition (EGFR-I) in the treatment of neuropathic pain. British journal of anaesthesia, 2015, Volume: 115, Issue:5 Topics: Adult; Aged; Analgesics, Non-Narcotic; Antibodies, Monoclonal; Cetuximab; ErbB Receptors; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gefitinib; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Pain Measurement; Panitumumab; Prospective Studies; Quinazolines; Recurrence; Young Adult	2015

Article

Year

Epidermal growth factor receptor-inhibition (EGFR-I) in the treatment of neuropathic pain.

British journal of anaesthesia, 2015, Volume: 115, Issue:5

Topics: Adult; Aged; Analgesics, Non-Narcotic; Antibodies, Monoclonal; Cetuximab; ErbB Receptors; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gefitinib; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Pain Measurement; Panitumumab; Prospective Studies; Quinazolines; Recurrence; Young Adult

2015